Global Hospital-acquired infections (HAIs) Control Market By Product Type (Diagnostic techniques, Dleaning and sterilization) And By End-Users/Application (General Hospital, Infectious Disease Hospital) Global Market Share, Forecast Data, In-Depth Analysis, And Detailed Overview, and Forecast, 2013 - 2026

According to Apex Market Research the Hospital-acquired infections (HAIs) Control market was valued at USD xx.xx million in 2019 and is anticipated to grow at a CAGR of xx% during the forecast period from 2020 to 2028. The report on Hospital-acquired infections (HAIs) Control market delivers detailed analysis covering major regional trends, market dynamics, and offer country-level market value of Hospital-acquired infections (HAIs) Control industry. Some of the major aspects considered during the course of research comprises definition of the product, classification of the product, industry structure, different participants in the Hospital-acquired infections (HAIs) Control ecosystem, etc. The report comprises of market value and forecast for the period from 2020 to 2028, CAGR measured for individual segment and regional market, competitive landscape of key market players, and profiling of major providers participating in the Hospital-acquired infections (HAIs) Control market.

The following manufacturers are covered in this report:
  • STERIS Corporation
  • Advanced Sterilization Products Division
  • Hoffmann-La Roche
  • Pfizer
  • Becton Dickinson

The report estimates on the Hospital-acquired infections (HAIs) Control market economy trend, market numbers (Mn/Bn USD) and CAGR from the 2020-2028, considering 2019 as the base year. A global Hospital-acquired infections (HAIs) Control market report consist of all leading industry players, Hospital-acquired infections (HAIs) Control business sections, company profile, revenue supply by Hospital-acquired infections (HAIs) Control industry sections, global Hospital-acquired infections (HAIs) Control market trends, acquisitions and arrangements, contact info, recent development, geographic examination and even more using the assistance.

Since the onset of COVID-19 in December 2019, the governments of various countries declared lockdown and as result numerous economies around the world experienced severe economic downturn. Since early 2020, the Hospital-acquired infections (HAIs) Control market witnessed the impact of COVID-19 The report objects to provide pre-COVID-19 state of the Hospital-acquired infections (HAIs) Control market in years 2020 and 2019 and moreover it offers forecast for the Covid-19 period from 2020 to 2028.The report provides COVID-19 impact on Hospital-acquired infections (HAIs) Control market, global analysis, different challenges or threats and opportunities for stakeholders involved in the Hospital-acquired infections (HAIs) Control market.

Report Opportunity: Global Hospital-acquired infections (HAIs) Control Market

This report delivers an analytical examination of the Hospital-acquired infections (HAIs) Control market summarized in broad sections such as
  1. Hospital-acquired infections (HAIs) Control Market Summary
  2. Key Commercial Growths in the Hospital-acquired infections (HAIs) Control Industry
  3. Market Dynamics Affecting the Hospital-acquired infections (HAIs) Control Industry
  4. Important Market Trends and Future Development Scenario of the Hospital-acquired infections (HAIs) Control Market
  5. Hospital-acquired infections (HAIs) Control Market Revenue and Forecast, by Type, 2018 – 2028
  6. Competitive Landscape of Hospital-acquired infections (HAIs) Control Industry
  7. Positioning of Main Market Players in the Hospital-acquired infections (HAIs) Control Industry
  8. Hospital-acquired infections (HAIs) Control Market Revenue and Forecast, by Application, 2018 - 2028
  9. Hospital-acquired infections (HAIs) Control Market Revenue and Forecast, by End-use, 2018 - 2028
  10. Hospital-acquired infections (HAIs) Control Market Revenue and Forecast, by Geography, 2018 - 2028
Hospital-acquired infections (HAIs) Control Market Segmentation:

The report provides detailed examination of the Hospital-acquired infections (HAIs) Control market on the basis of various segments such as type, application and end-use industry. The Hospital-acquired infections (HAIs) Control market is segmented as follows:

Hospital-acquired infections (HAIs) Control Market, by Type:
  • Diagnostic techniques
  • Dleaning and sterilization
  • Treatment
Hospital-acquired infections (HAIs) Control Market, by Application:
  • General Hospital
  • Infectious Disease Hospital
Geographic Coverage

The report on the Hospital-acquired infections (HAIs) Control market delivers an in depth country-level cross-sectional analysis across different regions around the globe. The report comprises of complete market value and forecast for the following countries and regions:

North America Hospital-acquired infections (HAIs) Control Market Revenue and Forecast
  • U.S.
  • Canada
Europe Hospital-acquired infections (HAIs) Control Market Revenue and Forecast
  • UK
  • Germany
  • France
  • Rest of Europe
Asia Pacific Hospital-acquired infections (HAIs) Control Market Revenue and Forecast
  • China
  • Japan
  • India
  • Rest of Asia Pacific
Latin America Hospital-acquired infections (HAIs) Control Market Revenue and Forecast
  • Mexico
  • Brazil
  • Rest of Latin America
Middle East and Africa Hospital-acquired infections (HAIs) Control Market Revenue and Forecast
  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summary
     2.1. Global Hospital-acquired infections (HAIs) Control Market Snapshot
          2.1.1. Global Hospital-acquired infections (HAIs) Control Market By Type,2019
               2.1.1.1.Diagnostic techniques
               2.1.1.2.Dleaning and sterilization
               2.1.1.3.Treatment
          2.1.2. Global Hospital-acquired infections (HAIs) Control Market By Application,2019
               2.1.2.1.General Hospital
               2.1.2.2.Infectious Disease Hospital
          2.1.3. Global Hospital-acquired infections (HAIs) Control Market By End-use,2019
          2.1.4. Global Hospital-acquired infections (HAIs) Control Market By Geography,2019

3. Global Hospital-acquired infections (HAIs) Control Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Hospital-acquired infections (HAIs) Control Market Size (US$), By Type, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Type, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Type, 2020
     4.2. Global Hospital-acquired infections (HAIs) Control Market Size (US$), By Type, 2018 – 2028

5. Global Hospital-acquired infections (HAIs) Control Market Size (US$), By Application, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By Application, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By Application, 2020
     5.2. Global Hospital-acquired infections (HAIs) Control Market Size (US$), By Application, 2018 – 2028

6. Global Hospital-acquired infections (HAIs) Control Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Hospital-acquired infections (HAIs) Control Market Size (US$), By End-use, 2018 – 2028

7. Global Hospital-acquired infections (HAIs) Control Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Hospital-acquired infections (HAIs) Control Market Analysis, 2018 – 2028 
          7.2.1. North America Hospital-acquired infections (HAIs) Control Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Hospital-acquired infections (HAIs) Control Market Size (US$), By Type, 2018 – 2028
          7.2.3. North America Hospital-acquired infections (HAIs) Control Market Size (US$), By Application, 2018 – 2028
          7.2.4. North America Hospital-acquired infections (HAIs) Control Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Hospital-acquired infections (HAIs) Control Market Analysis, 2018 – 2028 
          7.3.1.  Europe Hospital-acquired infections (HAIs) Control Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Hospital-acquired infections (HAIs) Control Market Size (US$), By Type, 2018 – 2028
          7.3.3. Europe Hospital-acquired infections (HAIs) Control Market Size (US$), By Application, 2018 – 2028
          7.3.4. Europe Hospital-acquired infections (HAIs) Control Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Hospital-acquired infections (HAIs) Control Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Hospital-acquired infections (HAIs) Control Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Hospital-acquired infections (HAIs) Control Market Size (US$), By Type, 2018 – 2028
          7.4.3. Asia Pacific Hospital-acquired infections (HAIs) Control Market Size (US$), By Application, 2018 – 2028
          7.4.4. Asia Pacific Hospital-acquired infections (HAIs) Control Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Hospital-acquired infections (HAIs) Control Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Hospital-acquired infections (HAIs) Control Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Hospital-acquired infections (HAIs) Control Market Size (US$), By Type, 2018 – 2028
          7.5.3. Latin America Hospital-acquired infections (HAIs) Control Market Size (US$), By Application, 2018 – 2028
          7.5.4. Latin America Hospital-acquired infections (HAIs) Control Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Hospital-acquired infections (HAIs) Control Market Analysis, 2018 – 2028 
          7.6.1.  MEA Hospital-acquired infections (HAIs) Control Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Hospital-acquired infections (HAIs) Control Market Size (US$), By Type, 2018 – 2028
          7.6.3. MEA Hospital-acquired infections (HAIs) Control Market Size (US$), By Application, 2018 – 2028
          7.6.4. MEA Hospital-acquired infections (HAIs) Control Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Hospital-acquired infections (HAIs) Control Providers
        8.4.1 STERIS Corporation
                8.1.1 Business Description
                8.1.2 STERIS Corporation Geographic Operations
                8.1.3 STERIS Corporation Financial Information
                8.1.4 STERIS Corporation Product Positions/Portfolio
                8.1.5 STERIS Corporation Key Developments
        8.4.2 Advanced Sterilization Products Division
                8.2.1 Business Description
                8.2.2 Advanced Sterilization Products Division Geographic Operations
                8.2.3 Advanced Sterilization Products Division Financial Information
                8.2.4 Advanced Sterilization Products Division Product Positions/Portfolio
                8.2.5 Advanced Sterilization Products Division Key Developments
        8.4.3 Hoffmann-La Roche
                8.3.1 Business Description
                8.3.2 Hoffmann-La Roche Geographic Operations
                8.3.3 Hoffmann-La Roche Financial Information
                8.3.4 Hoffmann-La Roche Product Positions/Portfolio
                8.3.5 Hoffmann-La Roche Key Developments
        8.4.4 Pfizer
                8.4.1 Business Description
                8.4.2 Pfizer Geographic Operations
                8.4.3 Pfizer Financial Information
                8.4.4 Pfizer Product Positions/Portfolio
                8.4.5 Pfizer Key Developments
        8.4.5 Becton Dickinson
                8.5.1 Business Description
                8.5.2 Becton Dickinson Geographic Operations
                8.5.3 Becton Dickinson Financial Information
                8.5.4 Becton Dickinson Product Positions/Portfolio
                8.5.5 Becton Dickinson Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Hospital-acquired infections (HAIs) Control Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Hospital-acquired infections (HAIs) Control Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Hospital-acquired infections (HAIs) Control Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Hospital-acquired infections (HAIs) Control Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Hospital-acquired infections (HAIs) Control Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Hospital-acquired infections (HAIs) Control Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Hospital-acquired infections (HAIs) Control Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Hospital-acquired infections (HAIs) Control Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Hospital-acquired infections (HAIs) Control Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Hospital-acquired infections (HAIs) Control Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Hospital-acquired infections (HAIs) Control Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Hospital-acquired infections (HAIs) Control Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Hospital-acquired infections (HAIs) Control Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Hospital-acquired infections (HAIs) Control Market Revenue, By Type, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Hospital-acquired infections (HAIs) Control Market Revenue, By Application, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Hospital-acquired infections (HAIs) Control Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Hospital-acquired infections (HAIs) Control: Market Segmentation 
FIG. 2 Global Hospital-acquired infections (HAIs) Control Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Hospital-acquired infections (HAIs) Control Market, By Type, 2019 (US$ Mn) 
FIG. 5 Global Hospital-acquired infections (HAIs) Control Market, By Application, 2019 (US$ Mn) 
FIG. 6 Global Hospital-acquired infections (HAIs) Control Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Hospital-acquired infections (HAIs) Control Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Hospital-acquired infections (HAIs) Control Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Hospital-acquired infections (HAIs) Control Providers, 2019
FIG. 11 Global Hospital-acquired infections (HAIs) Control Market Revenue Contribution, By Type, 2019 & 2028 (Value %) 
FIG. 12 Global Hospital-acquired infections (HAIs) Control Market Revenue Contribution, By Application, 2019 & 2028 (Value %) 
FIG. 13 Global Hospital-acquired infections (HAIs) Control Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Hospital-acquired infections (HAIs) Control Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Hospital-acquired infections (HAIs) Control Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Hospital-acquired infections (HAIs) Control Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Hospital-acquired infections (HAIs) Control Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Hospital-acquired infections (HAIs) Control Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Hospital-acquired infections (HAIs) Control market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 
1463

2135

OUR CLIENT